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Two new crystalline forms of permethylated b-cyclodextrin
are reported that contain methylglucose residues exclusively
in the 4C1 conformation, in contrast to the known mono-
hydrate, in which a single methylglucose residue adopts the
1C4 conformation.
In recent reports, we have focused on two intriguing aspects of the
solid-state chemistry of cyclodextrins, namely isostructurality and
polymorphism, both of which have practical implications for the
continued use of these molecules as drug carriers. Systematic
classification of the crystal structures of native and derivatised
cyclodextrins, and their inclusion complexes, into isostructural
series has proven useful in our laboratory for the definitive
identification from X-ray powder diffraction of new inclusion
complexes formed by these macrocyclic oligosaccharides.1 On the
other hand, crystal polymorphism, the inverse of isostructurality,2
was also demonstrated for cyclodextrins in our recent report on the
structural characterization of two crystalline forms of the inclusion
complex b-cyclodextrin–methyl paraben, isolated at different
temperatures.3
The present report relates to the polymorphism of permethylated
b-cyclodextrin [heptakis(2,3,6-tri-O-methyl)-b-cyclodextrin, com-
monly known as TRIMEB], widely used as a solubilising agent and
as host for the encapsulation of organic molecules,4 including
drugs.5 In 1994, we isolated single crystals of this host as the
monohydrate from an aqueous solution of TRIMEB maintained
at 50 uC. X-Ray structural analysis revealed that six of the seven
methylglucose residues adopt the normal 4C1 conformation while
the seventh is in the inverted 1C4 conformation.
6 A second structure
determination of this phase was subsequently reported.7 To our
knowledge, this remains the only known case of ring-inversion in
cyclodextrin solid-state chemistry. The resultant, highly distorted
conformation of the TRIMEB molecule contrasted strongly
with the more regular conformations it adopts in its inclusion
complexes.
We refer to the above crystal monohydrate as Form 1, in view of
our recent isolation of two new crystalline modifications of
TRIMEB, namely a trihydrate (Form 2) and an anhydrate (Form
3), which are the subject of this report. These new forms are
isostructural with respect to the host molecule, the latter having all
seven methylglucose residues in the normal 4C1 conformation.
Both crystal forms were isolated from failed attempts to obtain
inclusion complexes of TRIMEB with drug molecules.{ In all of
the experiments performed, the starting host material corresponded
to the known monohydrate, Form 1. The trihydrate (Form 2)
crystallised from a solution containing TRIMEB and the
antihypertensive drug atenolol (4-[2-hydroxy-3-[(1-methylethyl)-
amino)propoxy]benzeneacetamide, either in the form of enantio-
pure (S)-atenolol or as the racemate), in 1 : 1 host–guest molar
ratio, as well as from a solution containing TRIMEB and the
analgesic drug bucetin (N-(4-ethoxyphenyl)-3-hydroxybutanamide)
in 1 : 1 molar ratio. When the crystal of Form 2 obtained in the
latter case was maintained at 50 uC for several weeks, the anhydrate
Form 3 resulted. X-Ray diffraction data from single crystals of
both Forms 2 and 3 were collected and the structures were solved
and refined by routine procedures.§ The structure and conforma-
tion of the host molecule in the anhydrate Form 3 are shown in
Fig. 1, where the view is from the wider, secondary side of the
macrocycle. All methylglucose units adopt the usual 4C1 conforma-
tion and the structure is remarkably free of disorder.
Deviation from toroidal symmetry is usually described in terms
of the ‘tilt angle’,8 defined for each glucose residue Gn as the angle
between the plane O4Gn, C1Gn, C4Gn, O4G(n 2 1) and the mean
plane through the seven glycosidic oxygen atoms O4Gn (n ~ 1–7).
For the molecule depicted in Fig. 1, the tilt angle magnitudes span a
very wide range, namely 8.4(1)u for G4 to 72.0(1)u for G6,
indicating very significant distortions. The primary side of the
molecule is effectively blocked due to the unique orientation of
residue G6 coupled with the extended conformation of C5 A C9.
Although the tilt angle magnitudes in the TRIMEB molecule in
Form 1 span a similar range (4.6–72.9u), the presence of one
methylglucose residue in the inverted 1C4 conformation results in
the molecule adopting a distinctly elliptical shape.6 This collapsed
overall conformation was attributed mainly to the tendency for the
molecule to minimise the hydrophobic cavity size in the absence of
a guest molecule. The extent of ellipticity is measured by the seven
‘radial’ distances O4Gn…Cg, where Cg is the centre of gravity of
the seven O4Gn atoms. For Form 1, these radii span the range
3.41–5.94 Å, whereas in Form 3 (Fig. 1), the range is much
narrower viz. 4.49–5.50 Å. Examination of the crystal packing
revealed that the more ‘round’ shape of the TRIMEB molecule in
Form 3 is due to a much greater degree of ‘self-inclusion’ than is
observed in Form 1. Specifically, two primary methoxy groups of
one molecule insert into the secondary side of a neighbouring
molecule, as shown in Fig. 2. Space-filling models show that these
methoxy groups make van der Waals contacts with residue G6 and
its extended side chain C5 A C9.
The molecular conformation of TRIMEB in the trihydrate,
{ Electronic supplementary information (ESI) available: PXRD patterns
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Form 2, closely resembles that in Form 3, but interestingly, there is
molecular disorder in the former case (primary methoxy groups on
G1 and G3, each disordered over two positions; primary methoxy
C atom on G7 disordered over two positions). In addition, the
three water molecules associated with each TRIMEB molecule are
located outside the host cavity and are disordered over five sites.
They are arranged in discontinuous channels parallel to the crystal
b-axis where they are extensively hydrogen bonded to one another
and to host oxygen atoms.
The packing coefficients9 for Forms 2 and 3 are comparable at
67 and 64% respectively. Computation of the voids in the trihydrate
(Form 2) yielded a total potential solvent volume9 of only 51.5 Å3
per unit cell (0.6%), whereas for the anhydrate (Form 3), the
void volume is 467.2 Å3 (6.1%). The latter could accommodate
y3 water molecules per host molecule, which therefore implies that
dehydration of Form 2 to yield Form 3 leaves the crystal structure
essentially intact but more porous than the trihydrate phase. Close
examination showed that the positions of the relatively large voids
remaining in the Form 3 crystal structure coincide with cavities that
would result if the water molecules in Form 2 were to be artificially
removed. The dehydration process and its possible reversibility
have yet to be investigated but the mechanism of the former is likely
to involve small conformational changes of the host molecules to
permit the diffusion of water molecules through the bulk crystal, as
has been postulated for b-cyclodextrin hydrates,10 in which no
permanent channels exist.
We were first alerted to the existence of these new modifications
of TRIMEB from their unusually large crystal sizes (longest
dimension y3 mm) and their rounded, rhombic prismatic habits,
which contrast strongly with the flat, elongated prisms of Form 1.
In addition, the unit cell parameters for these crystal forms could
not be reconciled with those of previous crystals containing the
TRIMEB host molecule. Another distinguishing feature is the
common lower melting point of Form 2 (following dehydration)
and Form 3, namely 148 uC, compared with 157 uC for Form 1.11
Powder X-ray patterns of Forms 1, 2 and 3 were generated12 using
the single crystal X-ray data. As expected from the isostructurality
of Forms 2 and 3, their PXRD peak positions show very good
correlation, especially in the lower 2h angular range (see ESI{).
In conclusion, our report of the precipitation of Form 2 from
solutions of TRIMEB containing at least two different drug sub-
stances suggests that this new crystal form of the host may be
encountered more frequently in future and the characterization
data provided here should ensure its unequivocal identification. We
have noted the close structural analogy between the molecules of
atenolol and bucetin. This may be a factor in the crystallization of
Form 2 of TRIMEB in preference to the usual Form 1; we are
therefore investigating the effects of their analogues in crystal-
lization experiments with this host.
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Notes and references
{ 4 cm3 distilled water at 20 uC were added to a mixture of 10 mg
(0.038 mmol) of either (S)-atenolol or racemic atenolol and 50 mg
TRIMEB monohydrate, Form 1 (0.035 mmol). The mixture was placed on
ice and stirred for 19 h, filtered (0.45 mm) and the solution placed in an oven
at 60 uC. Crystals of Form 2 appeared after one month. Thermogravimetry
yielded a 3.3 ¡ 0.2% mass loss indicating 2.6–2.9 water molecules per
TRIMEB molecule. 1 cm3 of distilled water at 20 uC was added to a
mixture of 10 mg (0.045 mmol) bucetin and 64.8 mg (0.045 mmol)
TRIMEB monohydrate (Form 1) and the resultant stirred in a glass vial on
ice for 24 h. Further heating at 70 uC for 30 min and stirring for 30 min on
ice followed. The resulting solution was filtered (0.45 mm) and placed in an
oven at 50 uC. Large crystals of Form 2 appeared under the mother liquor.
The latter was allowed to evaporate and the crystals on the side of the vial
(uncovered by mother liquor) were harvested after one month and found to
be those of Form 3.
§ Intensity data were collected on a Nonius Kappa CCD diffractometer
using graphite-monochromated Mo–Ka X-rays (l ~ 0.71069 Å). Both
crystals were coated in Paratone oil (Exxon Chemical Co., TX, USA)
immediately after isolation and cooled in a stream of nitrogen vapour on
the diffractometer. The structures were solved by direct methods with
program SHELXS-9713 and refined using SHELXL-97.14 Crystal data for
Form 2: C63H112O35?3H2O, M ~ 1483.57, orthorhombic, space group
P212121, a ~ 16.2051(1), b ~ 16.2870(1), c ~ 30.0989(3) Å, U ~
7944.1(1) Å3, Z ~ 4, Dc ~ 1.240 g cm
23, T ~ 193(2) K, m(Mo–Ka) ~
0.102 mm21. Full-matrix least-squares refinement was based on 17 741
reflection data and yielded wR2 ~ 0.176 (all data), R1 [13 791 data with
F2 w 2s(F2)] ~ 0.0632, and goodness-of-fit on F2 ~ 1.026 (CCDC
239740). Crystal data for Form 3: C63H112O35, M ~ 1429.53,
orthorhombic, space group P212121, a ~ 15.9509(1), b ~ 16.5772(1),
c ~ 28.9413(2) Å, U ~ 7652.7(1) Å3, Z ~ 4, Dc ~ 1.241 g cm
23, T ~
173(2) K, m(Mo–Ka) ~ 0.101 mm21. Full-matrix least-squares refinement
was based on 14 499 reflection data and yielded wR2 ~ 0.130 (all data), R1
[13 091 data with F2 w 2s(F2)] ~ 0.0531, and goodness-of-fit on F2 ~
1.107 (CCDC 239741). See http://www.rsc.org/suppdata/cc/b4/b408660k/
for crystallographic data in .cif format.
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5 (a) K. H. Frömming and J. Szejtli, Cyclodextrins in Pharmacy, Kluwer,
Dordrecht, 1996, p. 25; (b) T. Loftsson and M. E. Brewster, J. Pharm.
Sci., 1996, 85, 1017; (c) K. Harata, K. Uekama, F. Hirayama and
M. Otagiri, J. Inclusion Phenom., 1988, 6, 443; (d) M. R. Caira,
V. J. Griffith, L. R. Nassimbeni and B. van Oudtshoorn, J. Inclusion
Phenom. Mol. Recogn. Chem., 1995, 20, 277.
6 M. R. Caira, V. J. Griffith, L. R. Nassimbeni and B. van Oudtshoorn,
J. Chem. Soc., Perkin Trans. 2, 1994, 2071.
7 T. Steiner and W. Saenger, Angew. Chem., Int. Ed., 1998, 37, 3404.
8 K. Harata, Bull. Chem. Soc. Jpn., 1979, 52, 2451.
9 A. L. Spek, J. Appl. Crystallogr., 2003, 36, 7.
10 T. Steiner and G. Koellner, J. Amer. Chem. Soc., 1994, 116, 5122.
11 V. J. Griffith, Physicochemical characterisation of cyclodextrin-drug
complexes, PhD thesis, University of Cape Town, South Africa, 1996.
12 K. Yvon, W. Jeitschko and E. J. Parthé, J. Appl. Crystallogr., 1977, 10,
73.
13 G. M. Sheldrick, Acta Crystallogr., Sect. A, 1990, A46, 467.
14 G. M. Sheldrick, SHELXL-97, Program for Crystal Structure Refine-
ment, University of Göttingen, Germany, 1997.
Fig. 2 Self-inclusion in Form 3 for molecules related by the screw axis
parallel to a.
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